We are live on ! Find out more
BSTG

Biostage, Inc. Common Stock
BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

53 hedge funds and large institutions have $16.7M invested in Biostage, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+53
Holders Change %
% of All Funds
1.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
53
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
51
Bank of America
North Carolina
$1K +$1.01K +215 New
AllianceBernstein
52
AllianceBernstein
Tennessee
+$182 +39 New
LTFS
53
Ladenburg Thalmann Financial Services
Florida
+$351 +75 New

BSTG Hedge Fund Activity: Q4 2013 in Review

53 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q4 2013, worth a combined $16.7M.

Buyers outnumbered sellers: 53 funds opened new BSTG positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock Institutional Trust, opening a new position worth an estimated $2.01M.

  • 53 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q4 2013, up from 0 in Q3 2013.
  • Funds reported $16.7M of Biostage, Inc. Common Stock stock for Q4 2013.
  • 53 funds opened new Biostage, Inc. Common Stock positions in Q4 2013 and 0 closed out, a net change of +53 holders.
  • The largest Biostage, Inc. Common Stock buyer in Q4 2013 was BlackRock Institutional Trust, an estimated $2.01M added.

Based on aggregated 13F filings for Q4 2013.